|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Departments of Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA; Department of Molecular and Cellular Physiology, Louisiana State University Health Sciences Center, Shreveport, LA, USA; The Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, LA, USA
2 Departments of Medicine, Louisiana State University Health Sciences Center, Shreveport, LA, USA; The Feist-Weiller Cancer Center, Louisiana State University Health Sciences Center, Shreveport, LA, USA
* To whom correspondence should be addressed. E-mail: kyeh{at}lsuhsc.edu.
Hepcidin has been implicated as the iron stores regulator: a hepatic signaling molecule that regulates intestinal iron absorption by undefined mechanisms. The possibility that hepcidin regulates the expression of ferroportin 1 (FPT1), the basolateral iron transporter was examined in rats after administration of lipopolysaccharide (LPS), an iron chelator, or His-tagged recombinant hepcidin (His-rHepc). In the liver, LPS stimulated a biphasic increase of hepcidin mRNA with peaks of mRNA at 6 h and 36 h. Concurrent ly hepatic FPT1 mRNA expression decreased to minimal level at 6 h and then increased with a peak at 24-36 h. LPS also induced biphasic changes in intestinal FPT1 mRNA expression with decreased levels at 6 h and increased expression at 48 h. While the initial decrease of FPT1 coincides with a LPS-induced decrease in serum iron, both intestinal and hepatic FPT1 expression recovered while serum iron concentration continued to decrease for at least 24 hours. Dietary iron ingestion increased intestinal ferritin protein production, but did not reduce intestinal FPT1 mRNA expression. The iron chelator pyrrolidinedithiocarbamate (PDTC) stimulated hepatic hepcidin without suppressing intestinal FPT1 expression. In PDTC-treated rats, LPS stimulated no additional hepatic hepcidin expression, but did increase intestinal FPT1 expression. Administration of His-rHepc induced significant reduction of intestinal FPT1 expression. Taken together, the data suggest that hepcidin mediates LPS-induced down regulation of intestinal FPT1 expression and that the hepcidin signaling pathway involves a PDTC-sensitive step.
This article has been cited by other articles:
![]() |
B. Chung, T. Chaston, J. Marks, S. K. Srai, and P. A. Sharp Hepcidin Decreases Iron Transporter Expression in Vivo in Mouse Duodenum and Spleen and in Vitro in THP-1 Macrophages and Intestinal Caco-2 Cells J. Nutr., August 1, 2009; 139(8): 1457 - 1462. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Jiao, J. Wilkinson IV, X. Di, W. Wang, H. Hatcher, N. D. Kock, R. D'Agostino Jr, M. A. Knovich, F. M. Torti, and S. V. Torti Curcumin, a cancer chemopreventive and chemotherapeutic agent, is a biologically active iron chelator Blood, January 8, 2009; 113(2): 462 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-y. Yeh, M. Yeh, L. Mims, and J. Glass Iron feeding induces ferroportin 1 and hephaestin migration and interaction in rat duodenal epithelium Am J Physiol Gastrointest Liver Physiol, January 1, 2009; 296(1): G55 - G65. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Theurl, M. Theurl, M. Seifert, S. Mair, M. Nairz, H. Rumpold, H. Zoller, R. Bellmann-Weiler, H. Niederegger, H. Talasz, et al. Autocrine formation of hepcidin induces iron retention in human monocytes Blood, February 15, 2008; 111(4): 2392 - 2399. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. P. Mena, A. Esparza, V. Tapia, P. Valdes, and M. T. Nunez Hepcidin inhibits apical iron uptake in intestinal cells Am J Physiol Gastrointest Liver Physiol, January 1, 2008; 294(1): G192 - G198. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. P Bressler, L. Olivi, J. H. Cheong, Y. Kim, A. Maerten, and D. Bannon Metal transporters in intestine and brain: their involvement in metal-associated neurotoxicities Human and Experimental Toxicology, March 1, 2007; 26(3): 221 - 229. [Abstract] [PDF] |
||||
![]() |
M. Constante, W. Jiang, D. Wang, V.-A. Raymond, M. Bilodeau, and M. M. Santos Distinct requirements for Hfe in basal and induced hepcidin levels in iron overload and inflammation Am J Physiol Gastrointest Liver Physiol, August 1, 2006; 291(2): G229 - G237. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. B Hadley, L. K Johnson, and J. R Hunt Iron absorption by healthy women is not associated with either serum or urinary prohepcidin Am. J. Clinical Nutrition, July 1, 2006; 84(1): 150 - 155. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Kelleher and B. Lonnerdal Zinc Supplementation Reduces Iron Absorption through Age-Dependent Changes in Small Intestine Iron Transporter Expression in Suckling Rat Pups J. Nutr., May 1, 2006; 136(5): 1185 - 1191. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kawabata, R. E. Fleming, D. Gui, S. Y. Moon, T. Saitoh, J. O'Kelly, Y. Umehara, Y. Wano, J. W. Said, and H. P. Koeffler Expression of hepcidin is down-regulated in TfR2 mutant mice manifesting a phenotype of hereditary hemochromatosis Blood, January 1, 2005; 105(1): 376 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Nemeth, M. S. Tuttle, J. Powelson, M. B. Vaughn, A. Donovan, D. M. Ward, T. Ganz, and J. Kaplan Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization Science, December 17, 2004; 306(5704): 2090 - 2093. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Krijt, M. Vokurka, K.-T. Chang, and E. Necas Expression of Rgmc, the murine ortholog of hemojuvelin gene, is modulated by development and inflammation, but not by iron status or erythropoietin Blood, December 15, 2004; 104(13): 4308 - 4310. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Lee, H. Peng, T. Gelbart, and E. Beutler The IL-6- and lipopolysaccharide-induced transcription of hepcidin in HFE-, transferrin receptor 2-, and {beta}2-microglobulin-deficient hepatocytes PNAS, June 22, 2004; 101(25): 9263 - 9265. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |